Clinical Trials Browser

Phase NA × OTHER × gemcitabine-oxaliplatin regimen × Clear all

NCT05215665 2024-12-11

GEMOX Combined With Targeted Therapy and Immunotherapy for Patients With Advanced Cholangiocarcinoma

Phase NA Unknown

Gastrointestinal

Cholangiocarcinoma